Clinical Trial Update: Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia Rheumatica [NA]

View source ↗

Summary

A clinical trial is planned to evaluate the efficacy and safety of Ivarmacitinib for polymyalgia rheumatica, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Ivarmacitinib

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Polymyalgia Rheumatics (PMR) | NA | Status: NOT_YET_RECRUITING